BioCentury
ARTICLE | Financial News

Northwest completes direct public offering

December 28, 2016 9:57 PM UTC

Northwest raised $10 million through the sale of 28.6 million shares at $0.35 in a direct public offering with institutional investors. Investors also received five-year warrants to purchase up to 14....

BCIQ Company Profiles

Northwest Biotherapeutics Inc.